CRT5 | CRT0066051 | CAS#1034297-58-9

MedKoo Cat#: 555943 | Name: CRT5

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CRT5 is a pyrazine benzamide that prevents activation of all three isoforms of PKD in endothelial cells treated with VEGF.

Chemical Structure

CRT5

CAS#1034297-58-9

Theoretical Analysis

MedKoo Cat#: 555943

Name: CRT5

CAS#: 1034297-58-9

Chemical Formula: C28H30N4O2

Exact Mass: 454.2369

Molecular Weight: 454.57

Elemental Analysis: C, 73.98; H, 6.65; N, 12.33; O, 7.04

Price and Availability

Size	Price	Availability
50mg	USD 450.00	2 Weeks
100mg	USD 750.00	2 Weeks
200mg	USD 1,250.00	2 Weeks
500mg	USD 2,850.00	2 Weeks
1g	USD 4,650.00	2 Weeks
2g	USD 6,950.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

CRT0066051; CRT-0066051; CRT 0066051; CRT5; CRT-5; CRT 5;

IUPAC/Chemical Name

3-[6-amino-5-(6-ethoxy-2-naphthalenyl)-3-pyridinyl]-N-[2-(dimethylamino)ethyl]-benzamide

InChi Key

XBDRAUPLGHAFCU-UHFFFAOYSA-N

InChi Code

InChI=1S/C28H30N4O2/c1-4-34-25-11-10-20-14-22(9-8-21(20)16-25)26-17-24(18-31-27(26)29)19-6-5-7-23(15-19)28(33)30-12-13-32(2)3/h5-11,14-18H,4,12-13H2,1-3H3,(H2,29,31)(H,30,33)

SMILES Code

O=C(NCCN(C)C)C1=CC=CC(C2=CC(C3=CC=C4C=C(OCC)C=CC4=C3)=C(N)N=C2)=C1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Certificate of Analysis

View CoA: current batch, Lot#A21O05B26

Safety Data Sheet (SDS)

View Safety Data Sheet (SDS)

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 454.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Echemendia RJ, Meeuwisse W, McCrory P, Davis GA, Putukian M, Leddy J, Makdissi M, Sullivan SJ, Broglio SP, Raftery M, Schneider K, Kissick J, McCrea M, Dvořák J, Sills AK, Aubry M, Engebretsen L, Loosemore M, Fuller G, Kutcher J, Ellenbogen R, Guskiewicz K, Patricios J, Herring S. The Concussion Recognition Tool 5th Edition (CRT5): Background and rationale. Br J Sports Med. 2017 Jun;51(11):870-871. doi: 10.1136/bjsports-2017-097508. Epub 2017 Apr 26. PMID: 28446450. 2: Evans IM, Bagherzadeh A, Charles M, Raynham T, Ireson C, Boakes A, Kelland L, Zachary IC. Characterization of the biological effects of a novel protein kinase D inhibitor in endothelial cells. Biochem J. 2010 Aug 1;429(3):565-72. doi: 10.1042/BJ20100578. PMID: 20497126; PMCID: PMC2907712. 3: Mohammadipoor A, Hershfield MR, Linsenbardt HR, Smith J, Mack J, Natesan S, Averitt DL, Stark TR, Sosanya NM. Biological function of Extracellular Vesicles (EVs): a review of the field. Mol Biol Rep. 2023 Oct;50(10):8639-8651. doi: 10.1007/s11033-023-08624-w. Epub 2023 Aug 3. PMID: 37535245. 4: Meeuwisse WH, Schneider KJ, Dvořák J, Omu OT, Finch CF, Hayden KA, McCrory P. The Berlin 2016 process: a summary of methodology for the 5th International Consensus Conference on Concussion in Sport. Br J Sports Med. 2017 Jun;51(11):873-876. doi: 10.1136/bjsports-2017-097569. Epub 2017 Apr 26. PMID: 28446449. 5: Zhou Z, Elledge SJ. Isolation of crt mutants constitutive for transcription of the DNA damage inducible gene RNR3 in Saccharomyces cerevisiae. Genetics. 1992 Aug;131(4):851-66. doi: 10.1093/genetics/131.4.851. PMID: 1516817; PMCID: PMC1205097. 6: Patil SP, Fattakhova E, Hofer J, Oravic M, Bender A, Brearey J, Parker D, Radnoff M, Smith Z. Machine-Learning Guided Discovery of Bioactive Inhibitors of PD1-PDL1 Interaction. Pharmaceuticals (Basel). 2022 May 16;15(5):613. doi: 10.3390/ph15050613. PMID: 35631439; PMCID: PMC9145945. 7: Vaarkamp J, Malde R, Dixit S, Hamilton CS. A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer. J Med Imaging Radiat Oncol. 2009 Jun;53(3):310-7. doi: 10.1111/j.1754-9485.2009.02078.x. PMID: 19624299. 8: Strain MM, Tongkhuya S, Wienandt N, Alsadoon F, Chavez R, Daniels J, Garza T, Trevino AV, Wells K, Stark T, Clifford J, Sosanya NM. Exploring combat stress exposure effects on burn pain in a female rodent model. BMC Neurosci. 2022 Dec 6;23(1):73. doi: 10.1186/s12868-022-00759-z. PMID: 36474149; PMCID: PMC9724288.